Hymexelsin
CAS No. 117842-09-8
Hymexelsin( ——— )
Catalog No. M38349 CAS No. 117842-09-8
Hymexelsin (Xeroboside) is an apiose-containing scopoletin glycoside, that can be isolated from the stem bark of Hymenodictyon excelsum.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHymexelsin
-
NoteResearch use only, not for human use.
-
Brief DescriptionHymexelsin (Xeroboside) is an apiose-containing scopoletin glycoside, that can be isolated from the stem bark of Hymenodictyon excelsum.
-
DescriptionHymexelsin (Xeroboside) is an apiose-containing scopoletin glycoside, that can be isolated from the stem bark of Hymenodictyon excelsum.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number117842-09-8
-
Formula Weight486.42
-
Molecular FormulaC21H26O13
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Prolactin Releasing ...
Prolactin Releasing Peptide (1-31), human is a high affinity GPR10 ligand that cause the release of the prolactin. Human and rat Prolactin Releasing Peptide (1-31) binds to GPR10 with Kis of 1.03 and 0.33 nM, respectively.Prolactin-releasing peptide is a specific prolactin releasing peptide.
-
Irsogladine
Irsogladine is an anti-gastric ulcer agent that facilitates gap-junctional intercellular communication through M1 muscarininc acetylcholine receptor binding.
-
Cavidine
Cavidine ((+)-Cavidine) is a selective COX-2 inhibitor which possesses anti-inflammatory activity. Cavidine can be used for the research of skin injuries, hepatitis, cholecystitis, and scabies. Cavidine ameliorates LPS -induced acute lung injury via NF-κB signaling pathway.
Cart
sales@molnova.com